Targeting the spectrum of immune checkpoints in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the spectrum of immune checkpoints in prostate cancer

Published:2021-07-15 Issue:10 Volume:14 Page:1253-1266
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Sena Laura A.¹,Denmeade Samuel R.¹²,Antonarakis Emmanuel S.¹²³^ORCID

Affiliation:

1. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2. Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

3. The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Funder

NCI Cancer Center Support Grant

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1949287

Reference163 articles.

1. The blockade of immune checkpoints in cancer immunotherapy

2. Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family

3. Enhancement of Antitumor Immunity by CTLA-4 Blockade

4. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

5. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance;Cancers;2024-08-08

2. Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit–risk ratio of immuno-oncology therapy;Proceedings of the National Academy of Sciences;2024-02-14

3. Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer;npj Genomic Medicine;2024-01-22

4. Knowledge mapping of immunotherapy in castration-resistant prostate cancer: a bibliometric and visualized study (2003–2022);Frontiers in Urology;2023-10-12

5. Current use of Molecular Mechanisms and Signaling Pathways in Targeted Therapy of Prostate Cancer;Current Pharmaceutical Design;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3